D-1302-2022 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- August 10, 2022
- Initiation Date
- July 21, 2022
- Termination Date
- April 18, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8022 bottles
Product Description
Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA; NDC 52544-691-30.
Reason for Recall
Failed Dissolution Specifications: below specification limits for dissolution.
Distribution Pattern
Nationwide in the USA and Puerto Rico
Code Information
Lot 1411593A, Exp 09/22